![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Deal date
KANDO id: 763556
Financial Transaction:
Series C
Poseida Therapeutics Inc
Currency
United States Dollar
Value in original currency
142,000,000
Value in USD
142,000,000
Lead investor
| Investor | Country | Notes | |
|---|---|---|---|
|
Novartis AG |
Round participants
| Investor | Country | Notes | |
|---|---|---|---|
|
Aisling Capital |
United States | |
|
Boxer Capital LLCBiotech investment firm. |
||
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Longitude Capital |
||
|
|
Malin Corp |
||
|
|
Pentwater Capital Management |
||
|
|
Perceptive Advisors |
United States | |
|
|
Rapha Capital Management |
||
|
Vivo Capital LLC |